Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploiting the folate receptor α in oncology.
Scaranti M, Cojocaru E, Banerjee S, Banerji U. Scaranti M, et al. Among authors: cojocaru e. Nat Rev Clin Oncol. 2020 Jun;17(6):349-359. doi: 10.1038/s41571-020-0339-5. Epub 2020 Mar 9. Nat Rev Clin Oncol. 2020. PMID: 32152484 Review.
Multidisciplinary interventions in a specialist Drug Development Unit to improve family history documentation and onward referral of patients with advanced cancer to cancer genetics services.
Moss CA, Cojocaru E, Hanwell J, Ward S, Xu W, van Zyl M, O'Leary L, de Bono JS, Banerji U, Kaye SB, Minchom A, George AJ, Lopez J, McVeigh TP. Moss CA, et al. Among authors: cojocaru e. Eur J Cancer. 2019 Jun;114:97-106. doi: 10.1016/j.ejca.2019.04.009. Epub 2019 May 16. Eur J Cancer. 2019. PMID: 31078974
What's the latest with investigational drugs for soft tissue sarcoma?
Cojocaru E, Napolitano A, Fisher C, Huang P, Jones RL, Thway K. Cojocaru E, et al. Expert Opin Investig Drugs. 2022 Nov;31(11):1239-1253. doi: 10.1080/13543784.2022.2152324. Epub 2022 Dec 5. Expert Opin Investig Drugs. 2022. PMID: 36424693 Review.
The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis.
Baldi GG, Brahmi M, Lo Vullo S, Cojocaru E, Mir O, Casanova M, Vincenzi B, De Pas TM, Grignani G, Pantaleo MA, Blay JY, Jones RL, Le Cesne A, Frezza AM, Gronchi A, Collini P, Dei Tos AP, Morosi C, Mariani L, Casali PG, Stacchiotti S. Baldi GG, et al. Among authors: cojocaru e. Oncologist. 2020 Nov;25(11):e1777-e1784. doi: 10.1634/theoncologist.2020-0352. Epub 2020 Jul 12. Oncologist. 2020. PMID: 32584482 Free PMC article.
Real-world experience with doxorubicin and olaratumab in soft tissue sarcomas in England and Northern Ireland.
Gennatas S, Chamberlain F, Carter T, Slater S, Cojocaru E, Lambourn B, Stansfeld A, Todd R, Verrill M, Ali N, Jones RL, Simmonds P, Keay N, McCarty H, Strauss S, Karavasilis V, Dileo P, Benson C. Gennatas S, et al. Among authors: cojocaru e. Clin Sarcoma Res. 2020 May 6;10:9. doi: 10.1186/s13569-020-00131-x. eCollection 2020. Clin Sarcoma Res. 2020. PMID: 32391141 Free PMC article.
Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers.
Smrke A, Younger E, Wilson R, Husson O, Farag S, Merry E, Macklin-Doherty A, Cojocaru E, Arthur A, Benson C, Miah AB, Zaidi S, Gennatas S, Jones RL. Smrke A, et al. Among authors: cojocaru e. JCO Glob Oncol. 2020 Jul;6:1046-1051. doi: 10.1200/GO.20.00220. JCO Glob Oncol. 2020. PMID: 32639877 Free PMC article.
158 results